News center

Dec 07, 2018

Frost & Sullivan recognizes power of connected medication adherence technology to drive value-based care

Estimated reading time: 2-4 minutes

Philips Medication Adherence Solution (PMAS) awarded Frost & Sullivan award for uniquely addressing the financial burden of medication noncompliance among high-risk patients

As health systems work to better manage high-risk, high-cost patient populations to successfully deliver value-based care, it’s critical that they have access to the appropriate patient data with actionable insights, and engage patients in their own care journey, including ensuring patients adhere to their treatment plans once they’re out of their provider’s sight. However, patients on complex medication regimes oftentimes fail to do so. Medication non-adherence costs the U.S. health system over $130 billion every year [1], and results in hundreds of thousands of preventable deaths annually [2]. Connected technology that provides care teams with visibility into patients’ medication adherence patterns helps build a foundation of intensive and ongoing care coordination, and helps cut costs of unplanned hospital visits. 

 

As part of its Best Practices awards, Frost & Sullivan recently awarded Philips with the 2018 North America Enabling Technology Leadership Award for its medication adherence solution that connects pharmacists, caregivers, patients and providers within a single platform, advancing the caregiving pathway from hospital to home. The Philips Medication Adherence Solution (PMAS) features an enterprise-grade medication dispenser that offers care providers data-driven insights to help optimize medication management and increase patient engagement. Each year, Frost & Sullivan present this award to a company that has developed a pioneering technology that not only enhances current products, but also enables the development of new solutions and applications.

With PMAS, patients with complex medication regimes can more easily manage their prescriptions
With PMAS, patients with complex medication regimes can more easily manage their prescriptions.

“To achieve the highest medication compliancy rate, it is important to have an integrated ecosystem that enables 100 percent transparency between the patient and various stakeholders along the care journey,” said Divyaa Ravishankar, Industry Principal & Associate Fellow, Transformational Health, Frost & Sullivan. “PMAS is the only solution that offers an integrated and connected environment, and Frost & Sullivan analysis supports the fact that, if used diligently, PMAS can have a disruptive impact on the overall healthcare expenditure.” 

 

To help facilitate the delivery of proactive and preventative care, Philips’ connected ecosystem includes a monitored in-home dispensing device, pre-packaged, unit-dose medications from mail order and specialty pharmacies, a clinician portal and a caregiver app. The advanced solution provides clinicians, pharmacists and caregivers with daily notifications of non-adherent patients, ensuring potential health risks are addressed before they escalate, while helping to drive down costs of medical complications related to non-adherence, such as unnecessary hospital admissions. PMAS provides the stability and transparency needed to help patients successfully manage their mediations, particularly for those with chronic conditions.

PMAS is the only solution that offers an integrated and connected environment, and Frost & Sullivan analysis supports the fact that, if used diligently, PMAS can have a disruptive impact on the overall healthcare expenditure.

Divyaa Ravishankar

Industry Principal & Associate Fellow, Transformational Health, Frost & Sullivan

“As healthcare moves towards the trend of decentralization, providers need solutions that activate their patients to manage their health within their homes,” said Derek Ross, Business Leader of Population Health Management at Philips. “Through our connected solutions, we aim to give our complex patients with a history of non-adherence the confidence to stay on track, and our health systems the ability to address the complexity of high-acuity patients and deliver better value-based care.”

 

To learn more about PMAS and Frost & Sullivan’s Best Practices awards, click here

 

[1] New England Health Care Institute (NEHI), 2009.

[2] National Council on Patient Information and Education. Accelerating Progress in Prescription Medicine Adherence: The Adherence Action Agenda. A National Action Plan to Address America’s “Other Drug Problem.” October 2013. http://bemedicinesmart.org

Philips’ connected ecosystem includes a monitored, in-home dispensing device to increase patient engagement

Philips’ connected ecosystem includes a monitored, in-home dispensing device to increase patient engagement.

 

To learn more about PMAS and Frost & Sullivan’s Best Practices awards, click here

 

[1] New England Health Care Institute (NEHI), 2009.

[2] National Council on Patient Information and Education. Accelerating Progress in Prescription Medicine Adherence: The Adherence Action Agenda. A National Action Plan to Address America’s “Other Drug Problem.” October 2013. http://bemedicinesmart.org

Share on social media

Topics

Contact

Kathy O'Reilly

Kathy O'Reilly

Philips Group Press Office

Tel.: +1 978-221-8919